Viewing Study NCT02867020


Ignite Creation Date: 2025-12-25 @ 4:14 AM
Ignite Modification Date: 2026-01-13 @ 5:49 PM
Study NCT ID: NCT02867020
Status: COMPLETED
Last Update Posted: 2021-07-07
First Post: 2016-08-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels
Sponsor: Latin American Cooperative Oncology Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module